Common Antibiotics, Dosages, and Treatment Regimens for SNF/LTC Patients
For urinary tract infections (UTIs)—the most common infection in SNF/LTC settings—use nitrofurantoin, trimethoprim/sulfamethoxazole, or pivmecillinam as first-line agents; for respiratory tract infections, use moxifloxacin for upper respiratory infections or doxycycline for lower respiratory infections, with treatment durations of 7–10 days. 1, 2, 3
Urinary Tract Infections (Most Common: 6.58 DDD per 1000 resident-days)
Diagnostic Approach
Before prescribing antibiotics, confirm the presence of systemic symptoms 1:
- Required for treatment: Fever (oral >37.8°C single reading or repeated >37.2°C), rigors/shaking chills, OR clear-cut delirium
- Plus at least one of: Recent-onset dysuria, frequency, urgency, incontinence, or costovertebral angle tenderness
Critical pitfall: Do NOT treat based solely on cloudy/malodorous urine, positive dipstick, or asymptomatic bacteriuria—these are extremely common in elderly residents and treating them drives antibiotic resistance 1, 4.
First-Line Antibiotic Regimens for UTI
Uncomplicated cystitis:
- Nitrofurantoin: 100 mg PO twice daily × 5–7 days 1, 2, 3
- Trimethoprim/sulfamethoxazole: 160/800 mg (1 DS tablet) PO twice daily × 7 days 1, 2
- Pivmecillinam: Standard dosing per local protocols 3
- Fosfomycin: 3 g single dose (alternative) 1
Complicated UTI or pyelonephritis:
- Fluoroquinolones (ciprofloxacin 500 mg PO twice daily or levofloxacin 750 mg PO daily) × 7–10 days 2
- Consider longer duration (10–14 days) for pyelonephritis
Catheter-associated UTI:
- Same principles apply; remove or change catheter if feasible 1
- Expect Pseudomonas in recently hospitalized patients 5
Resistance Considerations
Resistance rates in LTC are substantial 4:
- Trimethoprim/sulfamethoxazole: 30–70% resistance
- Fluoroquinolones: 25–60% resistance
- Third-generation cephalosporins: 15–40% resistance
- ESBL prevalence: 10–50% depending on region
For recently hospitalized patients with sepsis, empirically cover Pseudomonas aeruginosa while awaiting cultures 5.
Respiratory Tract Infections (Second Most Common: 5.34 DDD per 1000 resident-days)
Upper Respiratory Tract Infections
- Moxifloxacin: 400 mg PO daily × 5–7 days (most commonly prescribed) 2
- Phenoxymethylpenicillin (penicillin V): Standard dosing 3
Important caveat: Avoid treating viral URTIs with antibiotics—this is a major stewardship target 2.
Lower Respiratory Tract Infections/Pneumonia
- Doxycycline: 100 mg PO twice daily × 7–10 days 2
- Amoxicillin-clavulanate: 875/125 mg PO twice daily × 7–10 days 2, 6
- Moxifloxacin: 400 mg PO daily × 7–10 days (alternative) 2
Pneumonia in nursing homes occurs at 1 episode per 1000 resident-days (10-fold higher than community-dwelling elderly) and carries significant mortality 7.
Skin and Soft Tissue Infections
Cellulitis/Wound Infections
- First-generation cephalosporins (cephalexin 500 mg PO 3–4 times daily) × 7–10 days 6
- Amoxicillin-clavulanate: 875/125 mg PO twice daily × 7–10 days 6
For MRSA coverage (common in LTC residents with prior hospitalizations):
- Add or switch to agents with MRSA activity based on local resistance patterns 7
General Treatment Duration Principles
Treatment durations have appropriately decreased from 9.3 days (2007) to 7.3 days (2014) in LTC settings 2. Current evidence supports:
- Uncomplicated UTI: 5–7 days
- Complicated UTI/pyelonephritis: 7–14 days
- Pneumonia/LRTI: 7–10 days
- Skin/soft tissue: 7–10 days
Most Commonly Prescribed Antibiotics Overall in SNF/LTC
Based on actual utilization data 2, 6, 8:
- Fluoroquinolones (19% of prescriptions)—primarily ciprofloxacin, levofloxacin, moxifloxacin
- Beta-lactam/beta-lactamase inhibitors (11–18%)—amoxicillin-clavulanate
- Third-generation cephalosporins (20.8% in some settings)
- Sulfonamides (9%)—trimethoprim/sulfamethoxazole
- Tetracyclines (9%)—doxycycline
Critical Stewardship Considerations
Major drivers of inappropriate use 7, 2, 4:
- Treating asymptomatic bacteriuria (extremely common error)
- Treating viral URTIs with antibiotics
- Excessive treatment duration
- Indwelling catheter presence (14.5% of residents) 6
High-risk population characteristics in SNF/LTC 7, 6:
- Median age ~85 years
- 87% have cognitive impairment
- 90% have mobility limitations
- 92% have urinary/fecal incontinence
- Multiple comorbidities (diabetes, heart failure, dementia)
Antibiotic resistance reservoir: LTC facilities harbor MRSA, VRE, multidrug-resistant gram-negatives, and C. difficile, which residents carry across care settings during hospitalizations 7, 4.
Dosing Adjustments for Elderly
Elderly patients have declining renal function, reduced drug clearance, and polypharmacy risks 9. Adjust doses for creatinine clearance, particularly for:
- Fluoroquinolones
- Trimethoprim/sulfamethoxazole
- Nitrofurantoin (avoid if CrCl <30 mL/min)
Monitor for drug-drug interactions given average polypharmacy burden in this population 9.